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Introduction
How to increase the proportion of patients adhering to
their medication has been widely studied lately as well
as the reasons for non-adherence.1–4 Non-adherence
can be divided into intentional and unintentional
behaviour. Unintentional non-adherence has received
less attention than intentional non-adherence, and stu-
dies on unintentional non-adherence mostly focus
merely on patients and on how to help them to remem-
ber and to be able to take their medications.5,6 That
was also the starting point for our study trying to
find out why patients do not take their antithrombotic
medicines after a percutaneous coronary intervention
(PCI) procedure. From the national registry it was pos-
sible to determine which patients had not bought their
medications from the pharmacies and it turned out that
almost half of the patients had never bought a single
package of a P2Y receptor inhibitor (clopidogrel, pra-
sugrel or ticagrelor). However, the reason behind this
non-adherence was something we had not expected.
Expectations
A coronary patient having undergone a PCI could be
thought to be adherent to the medication, which is
planned to keep the arteries open and to prevent further
coronary attacks. It was a surprise to find that many
patients seemed not to take their medications as
expected. To find out the reasons behind this non-
adherence we decided to ask these patients for a specific
reason for their behaviour; whether they had too many
pills, had suffered from adverse drug events, or had any
other reasons, including financial problems, for not
buying the medicine even though medicines are subsi-
dised by the social security system in Finland and most
of these patients get their medications for a very low
price.
Methods and results
Because of ethical considerations, the patients were first
asked by mail for permission to contact them and to
enquire about details concerning their medications.
There were 152 patients who had undergone a PCI
during the first 6 months of the year 2012. Fifteen of
them had died and two patients had no present address.
An enquiry was sent to 135 patients and reasons for not
having bought their antithrombotic medicines were
asked. Seventy-six patients (56%) answered and 30 of
them were patients who, according to our statistics
from the social security institution, had not bought
their medications. These patients were contacted by
phone and the reasons for their non-adherence were
asked. They all answered that this antithrombotic
medication had never been prescribed for them.
Next step
In order to determine the reasons for non-adherence
most studies have concentrated on patients.7–10 There
have been fewer studies on unintentional non-
adherence caused by doctors. Lopez-Carmona et al.
performed an epidemiological study in Spain where
they found a significant gap between current guidelines
on recommended prescriptions and clinical practice to
make these prescriptions.11 However, the reasons
behind this practice were not studied and it remains
unknown whether this behaviour was intentional on
the part of the doctors. Our study showed that the rea-
sons for non-adherence may be more complicated and
connected to the system and medical practices, not only
to patients and doctors, as all the doctors were
undoubtedly fully aware of the clinical guideline to pre-
scribe antithrombotic medicine for at least 3 months
after a PCI. It seemed that there were many explan-
ations for the fact that these medications were not
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prescribed. One of them was that the PCI was per-
formed on a Friday, the patient went home during
the weekend and the paperwork was finalised first on
Monday. Consequently, there were three physicians
that had been involved in the treatment of the patient
and all of them thought someone else would have taken
care of the medications. Another example is that the
patient was asked to stop the antithrombotic for the
invasive treatment and had not understood that they
were supposed to restart after the procedure. It may be
that the presence of a pharmacist in the department, or
a less hierarchical system in the hospital, would help to
solve these kinds of problems.12 However, it should be
kept in mind that the reasons behind non-adherence
can be even more numerous than we have thought
and a thorough root-cause analysis is needed before
any final conclusions are drawn.
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